BioSignia Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 22

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

BioSignia General Information

Description

Developer of proprietary predictive modeling technologies to support healthcare, employee wellness, insurance and consumer health programs. The company's proprietary predictive modeling technologies specializes in providing risk assessment programs to proactively expose avoidable healthcare risks of individuals, enabling clients to predict morbidity and mortality outcomes and their associated cost impact with improved accuracy.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 401 Harrison Oaks Boulevard
  • Suite 120
  • Cary, NC 27513
  • United States
Primary Industry
Other Healthcare Technology Systems
Acquirer
Vertical(s)
Big Data, TMT
Corporate Office
  • 401 Harrison Oaks Boulevard
  • Suite 120
  • Cary, NC 27513
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioSignia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioSignia‘s full profile, request access.

Request a free trial

BioSignia Patents

BioSignia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150294420-A1 Systems, methods, and computer program products that facilitate life insurance underwriting with incomplete data Inactive 14-Apr-2014
US-20150234999-A1 Systems, methods and computer program products for determining a consolidated disease risk score from risk factors and a level of composite risk Inactive 18-Feb-2014
US-20120185274-A1 System and method for predicting inner age Inactive 14-Jan-2011
US-20070161868-A1 Method and system for determining whether additional laboratory tests will yield values beyond a threshold level Inactive 10-Jan-2006
EP-1179990-A1 System and method for predicting disease onset Inactive 26-Mar-1999 G16H50/20
To view BioSignia’s complete patent history, request access »

BioSignia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioSignia Acquisitions (1)

BioSignia’s most recent deal was a Merger/Acquisition with Doctors Direct Healthcare. The deal was made on 01-Jun-2012.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Doctors Direct Healthcare 01-Jun-2012 Merger/Acquisition Managed Care
To view BioSignia’s complete acquisitions history, request access »

BioSignia FAQs

  • When was BioSignia founded?

    BioSignia was founded in 1996.

  • Where is BioSignia headquartered?

    BioSignia is headquartered in Cary, NC.

  • What is the size of BioSignia?

    BioSignia has 22 total employees.

  • What industry is BioSignia in?

    BioSignia’s primary industry is Other Healthcare Technology Systems.

  • Is BioSignia a private or public company?

    BioSignia is a Private company.

  • What is BioSignia’s current revenue?

    The current revenue for BioSignia is .

  • How much funding has BioSignia raised over time?

    BioSignia has raised $329K.

  • When was BioSignia acquired?

    BioSignia was acquired on 06-Jun-2017.

  • Who acquired BioSignia?

    BioSignia was acquired by Orthus Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »